Anastomotic Leak Prediction: Biomarkers + AI vs Surgeon Judgment

Key Takeaways

Anastomotic leak prediction is evolving rapidly, with three distinct approaches showing different strengths and implementation timelines for surgical practice.

AI models achieve 99.6% accuracy but face practical barriers. Biomarker protocols offer negative predictive values of over 95% and immediate clinical use.

CRP levels on days 3-4 can detect leaks early, allowing intervention 1.5-3.5 days sooner than traditional methods.

Traditional surgeon judgment remains subjective and unreliable, with mean leak detection occurring 4.2 days post-surgery despite intraoperative assessment
Biomarker-based surveillance represents the most practical 2026 solution for most institutions, with CRP cutoffs of 140-190 mg/L showing consistent performance
Future success lies in multimodal systems combining biomarkers, AI, and clinical expertise rather than relying on any single prediction method

The evidence strongly supports the immediate adoption of biomarker protocols as part of AI integration preparations. Each anastomotic leak costs up to EUR 80,000 per patient, making accurate prediction systems essential for both patient outcomes and healthcare economics.

Anastomotic leak prediction has become critical, as each leak costs up to EUR 80,000 per patient. Colorectal surgeons have traditionally relied on intraoperative visual assessment and experience to judge anastomosis integrity. However, recent advances in biomarker analysis and artificial intelligence offer new detection methods. C-reactive protein (CRP) measurements on postoperative days 3-4 show a high negative predictive value, while machine learning models analyze laparoscopic images in real time. Studies across 9,120 patients have tested prediction models achieving an F1 score of 87%. This analysis compares surgeon judgment, biomarker-based approaches, and AI systems to determine which method best predicts anastomotic leaks in 2026.

What is Anastomotic Leak and Why Does Prediction Matter

Anastomotic leak is a defect in the intestinal wall at the surgical join, creating communication between intra- and extraluminal compartments. Incidence varies by location: ileocolic anastomoses leak at 1–3%, and coloanal at 10–20% [1]. Rectal anastomoses cause 75% of all leaks; overall colorectal surgery rates are 2.8–8.4% [2]. Right hemicolectomy has a 7.4% leak rate [3].

Clinical Impact: Morbidity, Mortality, and Cost Burden

Mortality associated with anastomotic leak in rectal surgery ranges from 1.7% to 16.4% [2], with colonic anastomoses showing higher mortality at 43.8% versus 7.1% for rectal anastomoses [1]. Patients who develop leaks have a 98% morbidity rate, compared with 28.4% in those without leaks [4]. The overall complication rate increases from 20% to 61% when leaks occur [2].

Hospital stays extend dramatically. Patients with leaks have an average hospitalization of 24.5 days, compared with 4.5 days for those without complications [2]. Mean length of stay ranges from 13 to 16.78 days for leak patients [4][5]. Reoperation rates range from 81.2% to 92.4% depending on surgical location [1], and intensive care unit admission is required in 62.6% of cases [1].

Economic burden is substantial. Incremental costs range from EUR 2,250 in Romania to EUR 83,633 in Brazil [6]. Leak patients have 108% higher mean inpatient costs (EUR 14,711) compared to uncomplicated cases (EUR 7,089) [7]. Key cost drivers include ward stay, disposables, OR use, and consultations [7]. Hospital reimbursement does not cover costs, resulting in average losses of EUR 2,041 per leak patient [7]. Societal burden, including productivity loss and rehabilitation, ranges from EUR 1.9 to 6.1 million [6].

Current Detection Challenges: The 5-7 Day Problem

Anastomotic leaks typically present on postoperative days 5-7, with resumption of bowel function [8]. The median time to diagnosis is 5-6 days post-surgery (range 1-85 days) [2]. One study reported diagnosis at 7.34 days after surgery [9]. Diagnosis may occur as late as 8.8 days postoperatively [10]. Symptoms include pain, nausea, vomiting, fever, tachycardia, peritonitis, and long ileus. Signs are often subtle and nonspecific, leading to missed diagnoses and false negatives. Symptoms usually show by day 5.8].

Early leaks occurring within 5 days are associated with severe general peritonitis requiring emergency relaparotomy [2]. Very early anastomotic leakage (within 5 postoperative days) is associated with peritonitis in 26.09% of cases, compared with 8.97% for late leaks [2]. By contrast, late leaks manifest as long-lasting pelvic abscess [2]. Presence of peritonitis drives the necessity of relaparotomy in 92% of cases [2].

Why Early Prediction Could Change Surgical Outcomes

Early detection proves critical for reducing morbidity and mortality [9]. Very early leaks prolong post-leakage hospital stays by 29.4 days, compared with 17.9 days [2]. Peritonitis presence extends to 34.9 versus 18.7 days [2]. Enhanced recovery protocols emphasize early discharge, creating an increased need for reliable prediction methods before patients leave the hospital [10].

Timely intervention increases the likelihood of conservative management rather than reoperation [10]. Conservative treatment includes antibiotics, nutritional support, and drainage, while patients with acute diffuse peritonitis or septic shock require immediate reoperation [9]. The postoperative drain/serum amylase ratio shows diagnostic value approximately 3.5 days postoperatively, 1.5 days earlier than conventional methods [10].

Identifying modifiable risk factors allows surgeons to optimize resource allocation, enhance patient preparation, and guide surgical technique selection [11]. Being that surgeons’ decisions on anastomosis versus diverting stoma rely on subjective risk estimation driven by personal experience and intraoperative findings [11], objective prediction tools provide a foundation for defensible clinical decisions in intermediate-risk patients.

Traditional Surgeon Judgment: The Current Standard

Surgeons assess anastomosis viability through multiple intraoperative techniques that have evolved over decades of clinical practice. The color of bowel edges, arterial bleeding from transected ends, and palpable pulsations of the mesenteric artery form the foundation of traditional assessment [12][13]. These methods remain subjective and operator-dependent, relying heavily on individual surgeon experience rather than objective measurements [13].

Visual Inspection and Intraoperative Assessment Techniques

The most commonly used method involves observing the color of the colonic wall and detecting pulses in small mesenteric vessels [13]. Surgeons inflate the gut at the anastomosis level to identify potential leakage sites through visual examination [14]. Intraoperative colonoscopy provides direct visualization of the anastomosis line, allowing evaluation of defects, bleeding, and ischemic changes [15]. The assistant surgeon inserts a flexible colonoscope through the anus while laparoscopic and colonoscopic monitors are positioned side-by-side, enabling simultaneous inspection [15]. Digital rectal examination is an alternative method for identifying the anastomosis site when air-leak testing is not performed [15].

Air Leak Testing and Perfusion Evaluation Methods

Air leak testing represents the most frequently performed mechanical integrity assessment. The procedure involves filling the pelvis with sterile normal saline and injecting approximately 50 mL of air per rectum while occluding the bowel proximal to the anastomosis [14][15]. Air bubbles in the saline indicate suture-line defects. The test requires about three minutes to complete [14]. Among 825 tested anastomoses, positive results occurred in 7.9%, with circular stapled procedures demonstrating 7.9% and handsewn anastomoses demonstrating 9.5% [16].

Perfusion assessment has expanded beyond visual inspection. Indocyanine green fluorescence angiography requires dye injection and subjective interpretation of tissue perfusion by the surgeon [13]. Studies report anastomotic leak rates of 3.8% with ICG imaging versus 7.5% without its use [12]. In one analysis, 11 patients (2.8%) required changes to the transection line due to fluorescence abnormalities, resulting in a 1% leak rate [17]. Analogous methods include laser speckle contrast imaging, which produces contrast-free perfusion measurements, and hyperspectral imaging, which offers real-time perfusion analysis without contrast agents [13]. The pooled anastomotic leak incidence across perfusion measurement studies was 7.4%, compared with 12.4% in control groups [13].

Experience-Based Risk Factor Identification

Surgeon volume influences anastomotic outcomes, with high-volume colorectal surgeons demonstrating lower complication rates than low-volume practitioners [17]. The surgeon represents the most important individual factor influencing anastomosis integrity [14]. Technique selection varies based on experience, including decisions between handsewn and stapled methods. Emergency surgery settings place patients at higher risk, functioning as an independent factor for anastomotic failure and post-leak mortality [17]. Operative time exceeding three hours is associated with increased anastomotic dehiscence incidence [17].

Limitations: Subjectivity and Late Detection Issues

Visual assessment proves unreliable even among experienced surgeons [18]. Interpretation remains subjective without standardized criteria, and misinterpretations occur despite extensive surgical experience [13]. Identifying blood vessels and palpating pulses becomes difficult in obese patients [13]. The mean detection time for leaks averages 4.2 days post-surgery (range 1-16 days), well after intraoperative assessment [15]. Air leak testing is subject to biomechanical uncertainty, as variations in patient anatomy make it difficult to determine the optimal air volume to achieve desired pressure levels [14]. Anastomoses rupture at pressures between 70 and 184 mmHg, yet no standardized burst-pressure analysis exists [14]. Moreover, the assessment of ICG signal intensity relies on subjective judgment, which introduces a risk of human error [12]. A learning curve exists, with experts suggesting more than 50 cases are needed to achieve proficiency [12].

Biomarker-Based Prediction: CRP, PCT, and Inflammatory Markers

Serum biomarkers offer quantifiable alternatives to subjective intraoperative assessment, with postoperative inflammatory markers emerging as objective tools for anastomotic leak prediction.

C-Reactive Protein (CRP): POD 3-4 Measurements and Cutoff Values

CRP follows a predictable pattern in uncomplicated cases, typically peaking around postoperative day 3 and declining thereafter [17]. Persistent elevation or secondary rises after POD 3 raise suspicion for complications [17]. Studies demonstrate remarkable consistency in identifying POD 3-4 as the optimal measurement timeframe [17].

Cutoff values range from 140 to 190 mg/L across multiple investigations. A threshold of 140 mg/L on POD 3 achieved 78% sensitivity and 86% specificity [19]. Other studies reported 180 mg/L on POD 4, yielding 72.3% sensitivity and 88.9% specificity with an AUC of 0.821 [20]. Robotic colorectal resections demonstrated lower thresholds: POD 3 CRP of 136.0 mg/L showed 73% sensitivity and 79% specificity [21], while POD 4 CRP of 94.4 mg/L achieved 84% sensitivity [21]. One analysis found 181.4 mg/L on POD 4 delivered 95% sensitivity and 90% specificity [22].

CRP levels exceeding 200 mg/L from POD 3 through 7 correlated with anastomotic leakage [20]. When combined with early warning scores, a cutoff of 180 mg/L on POD 3 produced an AUC of 0.89 with 90% sensitivity [20]. Changes exceeding 50 mg/L between consecutive postoperative days had a sensitivity of 0.85 and a negative predictive value of 0.99 [20].

Procalcitonin (PCT): Enhanced Specificity for Infectious Complications

PCT demonstrates greater specificity for bacterial infections and sepsis compared to CRP [20]. On POD 3, an optimal cutoff of 5.27 ng/mL resulted in 100% sensitivity, 85% specificity, and 100% negative predictive value [21]. Mean PCT values in leak patients reached 25.48 ng/mL versus 4.71 ng/mL in non-leak groups [21].

PCT levels below 5 ng/mL on POD 3 or below 2.0 ng/mL on POD 5, combined with low CRP values, support safe discharge protocols [20]. On POD 5, mean PCT levels were 9.02 ± 15.92 ng/mL in patients with leakage, compared with 2.63 ± 1.52 ng/mL in patients without leakage [20]. A cutoff of 0.31 ng/mL on POD 5 achieved 100% sensitivity and 72% specificity for major leaks [17]. PCT below 2.33 ng/mL on POD 5 yielded 98.1% NPV and 91.3% specificity [20].

The combination of PCT and CRP measurements on POD 3 and POD 5 produced AUC values of 0.87 and 0.94, respectively [20]. In contrast, PCT alone on POD 5 showed an AUC of 0.86 [20]. PCT outperformed CRP at POD 3, with an AUC of 0.791 versus 0.756, though both achieved similar performance at POD 5, approximately 0.867-0.871 [20].

White Blood Cell Count and Novel Inflammatory Indices

WBC count at a cutoff of 6,200/μL demonstrated 81.8% sensitivity and 98.4% negative predictive value [21]. Mean WBC levels were 7000±2200/μL in leak groups versus 5600±1700/μL in non-leak groups [21].

The neutrophil-to-lymphocyte ratio (NLR) at a cutoff of 7.1 on POD 4 had the best AUC (0.744), with 72.7% sensitivity and 73.4% specificity [19]. The derived NLR (dNLR) achieved an AUC of 0.732 at a cutoff of 3.8 [19]. NLR, dNLR, and platelet-to-lymphocyte ratio (PLR) were higher in leak patients on POD 1 and POD 4, with greater differences on POD 4 [19]. The NLR on POD 6, with a ratio of 6.77, produced 95% NPV and an AUC of 0.86 [22].

Peritoneal Fluid Biomarkers: IL-6, IL-10, and TNF-α

Peritoneal IL-6 levels proved higher in leak patients on POD 1-3 [23][24]. Meta-analysis revealed leak patients had higher IL-6 levels on POD 1 (MD: 48.72), POD 2 (MD: 29.90), and POD 3 (MD: 42.74) [24]. Local markers demonstrated higher sensitivity and specificity compared to systemic markers [17].

TNF-α levels showed elevation on POD 4 in leak patients (MD: 1.26) [24]. However, TNF-α showed no difference between groups on POD 1-3 or POD 5 [24]. IL-1β and IL-10 exhibited no difference between leak and non-leak patients [24][24].

Clinical Performance: Sensitivity, Specificity, and NPV Metrics

CRP consistently demonstrated NPV exceeding 95% across multiple studies [17], with values reaching 97.2% at a 180 mg/L cutoff on POD 4 [20] and 99% at a 181.4 mg/L cutoff [22]. PCT showed similarly high NPV of 96.7% on POD 3 and POD 5 [20]. The positive predictive value remained lower, ranging from 20-24% for CRP [20][24], indicating elevated levels trigger further assessment rather than confirming diagnosis. Pooled AUC values for CRP on POD 3 and 5 ranged from 77.9% to 87.1% [21], while PCT demonstrated a pooled sensitivity of 80.7% and specificity of 84.9% on POD 5 [21].

AI and Machine Learning Models for Leak Prediction

Machine learning algorithms analyze complex, nonlinear relationships among clinical variables, enabling more precise predictions than traditional scoring systems or clinical judgment alone [20]. Convolutional neural networks have emerged as the dominant architecture for analyzing laparoscopic video data during colorectal procedures.

Deep Learning Models: CNN Architectures and Video Analysis

A multicenter study across three international high-volume centers trained CNNs on 5,356 annotated frames from 26 patients, with 2,007 frames showing colorectal anastomotic leaks and 3,349 demonstrating normal anastomoses [25]. Four distinct architectures underwent evaluation: EfficientNetB0, EfficientNetB7, ResNet50, and MobileNetV2 [25]. ResNet18 achieved the highest recall values in gastric surgery applications, reaching 0.8474 for duodenal stump and 0.8000 for esophagojejunal anastomoses, with F1 scores of 0.6357 and 0.6938, respectively [19].

Intraoperative Real-Time Prediction Using Laparoscopic Images

Real-time surgical systems demonstrate the capacity for immediate intraoperative feedback. One intelligent surgical assistant achieved 89% accuracy in instrument tracking and organ segmentation during laparoscopic hemi-hepatectomy [21]. Phase classification accuracy reached 91%, with critical phases identified at area under the curve values of 0.96 for Phase 1 and 0.87 for Phase 5 [21]. The system maintained computational efficiency with 52ms inference latency per frame, corresponding to 19.2 frames per second, sufficient for generating intraoperative real-time feedback [21].

Machine Learning Meta-Models: Combining Multiple Algorithms

Meta-models integrate predictions from multiple base algorithms to enhance accuracy. A cross-attention-based neural network combined outputs from CatBoost, LightGBM, random forest, and bagging classifier models trained on data from 9,120 patients across 13 centers [20]. The multihead self-attention mechanism analyzed embeddings by dividing them into multiple attention heads, whereas the cross-attention layer computed associations between base model predictions and feature representations [20].

Performance Metrics: 99.6% Accuracy and AUROC Scores

The best-performing CNN model achieved an accuracy of 99.6%, an AUROC of 99.6%, a sensitivity of 99.2%, a specificity of 100.0%, a positive predictive value of 100.0%, and a negative predictive value of 98.9% [25]. The meta-model demonstrated F1 scores of 87% in cross-validation and 70% in external validation [20]. Statistical analysis revealed that the meta-model outperformed the individual components, achieving better results than LightGBM (p=0.0009), random forest (p=0.0005), and bagging classifier (p=0.0035) [26].

Explainable AI: Heatmaps and Visual Prediction Explanations

Grad-CAM visualization generates heatmaps identifying image regions influencing predictions [25]. These heatmaps revealed that both staple lines and surrounding organs contributed to classification decisions in anastomotic leak prediction [19]. Heat maps showed high-intensity responses localized to regions of surgical manipulation, reflecting the network’s accurate anatomical comprehension [21]. This explainability mechanism builds surgeon confidence in model decisions and potentially guides intraoperative interventions in areas with elevated anastomotic leak risk [24].

Head-to-Head Comparison: Biomarkers vs AI vs Surgeon Judgment

Three distinct methodologies for anastomotic leak prediction differ substantially in performance metrics, temporal application, and practical feasibility.

Accuracy and Predictive Value Comparison Across Methods

The meta-model combining machine learning algorithms achieved F1 scores of 87% (95% CI, 78%-95%) during cross-validation across 13 centers, though external validation demonstrated lower performance at 70% [11]. Statistical testing confirmed superiority over individual components, outperforming LightGBM (p=0.0009), random forest (p=0.0005), and bagging classifier (p=0.0035) [11]. By contrast, convolutional neural networks analyzing laparoscopic images reached 99.6% accuracy with an AUROC of 99.6%, a sensitivity of 99.2%, and a specificity of 100.0% [24].

Clinical scoring systems showed more modest results. The CF-ALPS model achieved an ROC AUC of 0.82 (95% CI: 0.75-0.89) with 85.0% sensitivity and 78.0% specificity [27]. However, cross-validation analysis yielded an average ROC AUC of only 0.44 (SD = 0.062), indicating moderate accuracy in predicting anastomotic leakage across data splits [27].

Traditional surgeon assessment remains largely subjective, heavily reliant on clinical suspicion and individual judgment [24]. Conventional diagnostic approaches are employed reactively after symptom onset, with intraoperative techniques offering limited predictive accuracy influenced by surgeon experience and interpretation [24].

Timing of Detection: Intraoperative vs Postoperative Days 3-5

AI-powered systems provide real-time intraoperative feedback, potentially enabling immediate surgical decision-making during the procedure [24]. This represents a paradigm shift toward preventive interventions rather than reactive management.

Biomarker protocols function postoperatively, with CRP and PCT measurements on days 3-5 offering high negative predictive value for ruling out anastomotic leakage [24]. Clinical assessment and laboratory markers help exclude leaks but are less effective at predicting their occurrence [24]. This reactive pathway limits opportunities for early intervention, as investigations typically initiate only after patients become symptomatic [24].

Cost-Effectiveness Analysis: Laboratory Tests vs AI Infrastructure

AI implementation in hepatocellular carcinoma detection demonstrated an incremental cost-effectiveness ratio of EUR 9,888 per QALY gained, below the EUR 33,000 willingness-to-pay threshold [17]. Cost savings in treatment reached USD 289,634.83 per day per hospital in the tenth year [22].

Biomarker monitoring incurs routine laboratory costs that must be weighed against potential savings from prevented complications and reduced length of stay [20]. The high negative predictive value suggests potential cost savings through confident early discharge of low-risk patients [20].

Real-World Clinical Utility and Practical Implementation

AI-based models face implementation barriers owing to computational requirements and limited feasibility in resource-constrained settings [27]. Current models typically require extensive preoperative assessment and may not integrate readily into routine surgical workflows [27].

Machine learning applications for biomarker interpretation represent an emerging frontier, as complex patterns of multiple biomarkers combined with clinical variables prove ideal for such tools [20]. This integration could optimize the timing of interventions and provide more accurate risk prediction than isolated methods [20].

Score Prediction of Anastomotic Leak in Colorectal Surgery: A Systematic Review

Structured scoring systems emerged from systematic reviews identifying risk factors across multiple studies, offering standardized frameworks for anastomotic leak prediction.

Colon Leakage Score (CLS) and Modified CLS

Development of the Colon Leakage Score involved systematic literature searches across PubMed and Cochrane Library from January 1990 to September 2010, analyzing studies with search terms combining “anastomotic leakage and colorectal surgery” with “risk factor” keywords [28]. The initial search yielded 221 studies, from which 64 met the inclusion criteria [28]. Consensus on risk factor inclusion and weighting required four iterations [28]. Modified versions have since been developed to enhance predictive accuracy in specific patient populations.

DULK Score: 13 Parameters for Risk Assessment

The Dutch Leakage (DULK) score tracks laboratory and clinical parameters recorded daily during the postoperative period. Validation studies demonstrated sensitivity of 91.7%, specificity of 55.7%, positive predictive value of 22%, and negative predictive value of 98%, with an AUROC of 0.83 [19]. A cutoff score greater than 3 provided optimal early diagnostic performance [19]. Consequently, routine DULK scoring enables anastomotic leak diagnosis 3.5 days earlier than clinical judgment alone [19].

The score proved superior to isolated biomarkers, outperforming CRP and procalcitonin in both sensitivity and specificity [19]. Alternative validation research established a cutoff value of 8, achieving 84.37% sensitivity, 79.62% specificity, 71.05% positive predictive value, and 89.58% negative predictive value [29]. Modified DULK variants utilize fewer parameters, including abdominal pain, tachypnea, CRP elevation, and clinical deterioration [29].

ISREC Grading System and Severity Classification

The International Study Group of Rectal Cancer proposed a definition and severity grading applicable to sphincter-preserving rectal resections [30]. Among 746 patients, with an overall leak rate of 7.5%, the distribution across severity grades was 16% Grade A, 23% Grade B, and 61% Grade C [30]. Grades B and C patients exhibited higher CRP levels than Grade A patients [30]. The ISREC definition is employed by 71% of survey participants [31]. This grading system reflects both the patient’s clinical condition and the status of the anastomotic site [32].

Combining Scores with Biomarkers for Enhanced Accuracy

Integration of early warning scores with CRP measurements on POD 3 produced an AUC of 0.89 with 90% sensitivity when thresholds of 2.4 for EWS and 180 mg/L for CRP were applied [33]. This multimodal approach stratifies patients into high-risk and low-risk categories for anastomotic failure [33].

Clinical Implementation Challenges and Solutions

Deployment of advanced anastomotic leak prediction systems encounters multiple barriers that extend beyond technical performance metrics.

Integration into Surgical Workflow and Decision-Making

Lack of standardization and limited integration into curricula represent common obstacles [26]. Routine adoption requires addressing data quality, model generalizability, and validation across diverse clinical settings [34]. Additional prospective studies remain necessary to assess the clinical utility in real-time environments and to evaluate seamless workflow integration [35]. User-friendly tools for real-time decision-making, including web-based calculators and decision support systems, can guide surgical planning [34]. AI-driven predictions of high anastomotic leak risk may prompt interventions such as selective use of diverting stomas or intensified postoperative monitoring [34].

Training Requirements for AI Systems and Biomarker Protocols

Development of robust models depends on multicenter, diverse datasets and collaborative efforts between institutions [34]. High-quality biospecimens processed, stored, and sectioned according to identical clinical protocols are essential, accompanied by appropriate patient demographic, clinical, and molecular data [36]. Transparency and interpretability require techniques such as SHAP values and feature importance analysis to increase clinician trust in AI-driven recommendations [34]. However, developing convolutional neural networks based on large patient populations with anastomotic leaks, including those with protective stomas, remains dependent on extensive data collection [21].

Ethical Considerations: Responsibility and Liability Issues

A concise definition of responsibilities in the event of an error or misdiagnosis requires a clear framework [21]. The surgeon interprets AI predictions and decides whether to modify anastomosis, create derivative stomas, or avoid anastomosis in high-risk patients [21]. Data collection must respect current legal frameworks, which proves fundamental to developing multimodal explainable AI models [21]. Bias in predictive models can arise during data collection, where choices about which data to gather significantly affect model fairness [37].

How Do You Fix an Anastomotic Leak: Prevention vs Treatment Strategies

Management approaches have evolved beyond surgical revisions to include conservative measures, antibiotics, and endoscopic therapies [38]. Prevention encompasses patient optimization through comorbidity management, smoking cessation, and adequate nutrition [38]. Surgeon experience is crucial, as is preserving the blood supply, creating a tension-free anastomosis, and conducting intraoperative leak testing [38]. Treatment options depend on leak severity, timing, location, and patient clinical status, ranging from antibiotics alone and radiological-guided drainage to surgery for hemodynamically unstable patients [8].

Future Directions: Multimodal Prediction Systems for 2026 and Beyond

The convergence of biomarker analysis, artificial intelligence, and clinical expertise marks a paradigm shift in postoperative monitoring strategies for colorectal anastomosis [20][39]. This multimodal approach addresses limitations inherent in isolated prediction methods.

Combining Biomarkers, AI, and Clinical Judgment

Machine learning applications for interpreting biomarker data represent an exciting frontier [20][39]. Complex patterns of multiple biomarkers, combined with clinical variables and patient characteristics, prove ideal for AI tools that potentially provide more accurate risk prediction and optimize intervention timing [20]. Multimodal AI systems examine cross-domain relationships, uncovering hidden connections and mitigating cognitive blind spots [25]. For instance, integrating demographic, immune status, imaging, and pharmacogenetic data enables the identification of high-risk individuals who might benefit from early intervention [25].

The ability to stratify patients based on biochemical profiles opens the door to tailored monitoring strategies [20][39]. Patients demonstrating favorable biomarker trends might benefit from accelerated recovery protocols and earlier discharge, while those showing concerning patterns could receive intensified surveillance and preemptive interventions [20][39]. This approach aligns with precision medicine principles in surgical care [20].

Point-of-Care Testing and Rapid Biomarker Analysis

Implementing CRP-based screening protocols with triggers exceeding 150 mg/L at POD 3 or 125 mg/L at POD 4 led to earlier detection, increased anastomotic preservation rates, and reduced complication severity [39]. This real-world validation supports the practical utility of biomarker-based surveillance strategies [39]. Combining biomarkers increases diagnostic precision beyond single markers, though no isolated biomarker definitively detects anastomotic leak [40].

Enhanced Recovery Protocols with Predictive Analytics

Integration of biomarker monitoring into enhanced recovery after surgery protocols represents a promising area of development [20][39]. Objective biochemical data help optimize ERAS pathways and provide confident decision-making regarding patient progression through recovery milestones [20][39]. Analysis of CRP and WBC on POD 3, together with PCT concentrations on POD 5, proves crucial for early detection in both open and laparoscopic procedures [41].

Comparison Table

Comparison Table: Anastomotic Leak Prediction Methods

Attribute	Traditional Surgeon Judgment	Biomarker-Based Prediction	AI/Machine Learning Models
Primary Methods	Visual inspection, air leak testing, perfusion assessment (ICG fluorescence), palpation of mesenteric vessels	CRP (POD 3-4), PCT (POD 3-5), WBC count, NLR, peritoneal fluid markers (IL-6, TNF-α)	CNN architectures (EfficientNet, ResNet, MobileNet), meta-models combining multiple algorithms, and laparoscopic video analysis
Timing of Detection	Intraoperative (during surgery)	Postoperative days 3-5	Real-time intraoperative with 52ms inference latency (19.2 fps)
Sensitivity	Variable, operator-dependent; ICG studies show 2.8% requiring transection changes.	CRP: 72.3-95%; PCT: 100% (POD 3 at 5.27 ng/mL cutoff); WBC: 81.8%	CNN models: 99.2%; Meta-model: 87% F1 score (cross-validation)
Specificity	Subjective: ICG leak rate 3.8% vs 7.5% without; Air leak test positive in 7.9% of cases	CRP: 86-90%; PCT: 85-91.3%; WBC: Not mentioned	CNN models: 100%; Meta-model: Not individually specified
Negative Predictive Value (NPV)	Not quantified	CRP: >95% (up to 99%); PCT: 96.7-100%; WBC: 98.4%	CNN models: 98.9%
Positive Predictive Value (PPV)	Not quantified	CRP: 20-24%; PCT: Not extensively reported	CNN models: 100%
AUROC/AUC	Not applicable	CRP: 0.77-0.89; PCT: 0.86-0.94; NLR: 0.73-0.86	CNN models: 99.6%; Meta-model: Not specified; CF-ALPS score: 0.82
Accuracy	Unreliable even among experienced surgeons; subjective interpretation	High NPV enables confident exclusion of leaks; lower PPV requires further assessment	CNN models: 99.6%; Meta-model: 70% (external validation)
Objectivity	Highly subjective, operator-dependent, and relies on individual experience	Objective, quantifiable measurements with standardized cutoff values	Objective, algorithmic analysis with explainable AI heatmaps
Detection Timeline	Mean 4.2 days post-surgery (range 1-16 days) for actual leaks despite intraoperative assessment.	Optimal measurement POD 3-4 for CRP, POD 3-5 for PCT; enables detection 1.5-3.5 days earlier than conventional methods.	Immediate intraoperative feedback; potential for preventive intervention
Cost Considerations	Standard surgical practice; no additional equipment costs for basic assessment; ICG requires specialized equipment	Routine laboratory costs; high NPV enables cost savings through confident early discharge	AI in HCC detection: EUR 9,888 per QALY; treatment savings USD 289,634.83 per day per hospital (year 10)
Key Advantages	Immediate assessment during surgery allows real-time surgical modifications; established practice.	High NPV (>95%) for ruling out leaks; objective measurements; supports safe early discharge protocols	Highest accuracy metrics; real-time feedback; analyzes complex nonlinear relationships; explainable predictions via heatmaps.
Key Limitations	Subjective interpretation; unreliable visual assessment; difficult in obese patients; learning curve >50 cases for ICG; late detection (4.2 days average); no standardized burst pressure analysis	Postoperative timing limits preventive intervention; lower PPV (20-24%); requires waiting until POD 3-5; reactive rather than preventive.	Computational requirements; limited feasibility in resource-constrained settings; requires extensive training datasets; implementation barriers; needs multicenter validation.
Learning Curve	Extensive surgical experience required; >50 cases needed for ICG proficiency	Standardized protocols with established cutoff values; minimal interpretation required	Requires high-quality, diverse datasets; collaborative institutional efforts; and transparency mechanisms needed for clinician trust
Clinical Utility	Enables intraoperative decisions on anastomosis vs diverting stoma; subjective risk estimation	Stratifies patients for monitoring intensity; supports enhanced recovery protocols; triggers further assessment when elevated.	Guides immediate surgical interventions; identifies high-risk areas; may prompt selective diverting stoma or intensified monitoring
Implementation Challenges	Variability between surgeons, biomechanical uncertainty in air leak testing, and misinterpretation despite experience	Integration into ERAS protocols requires a consistent laboratory infrastructure.	Lack of standardization; limited curriculum integration; workflow integration barriers; ethical/liability considerations; data quality requirements
Evidence Base	Air leak testing in 825 anastomoses; ICG studies showing 3.8% vs 7.5% leak rates; pooled leak incidence 7.4% vs 12.4% in controls	Studies across multiple centers with consistent POD 3-4 timing; meta-analyzes confirming performance.	Multicenter study with 5,356 annotated frames from 26 patients; meta-model trained on 9,120 patients across 13 centers

Conclusion

The battle between prediction methods remains nuanced rather than definitive. AI models achieve superior accuracy metrics at 99.6%, yet implementation barriers persist. Biomarker protocols offer practical utility now, particularly CRP measurements on postoperative days 3-4 with negative predictive values exceeding 95%. Traditional surgeon judgment provides immediate intraoperative assessment but is subject to bias. For most institutions in 2026, biomarker-based surveillance represents the most feasible immediate solution. High-volume centers with technical infrastructure might implement AI-assisted analysis. The future likely belongs to multimodal systems combining all three approaches. Consequently, surgeons should adopt biomarker protocols immediately while monitoring AI developments for eventual integration into standard practice.

Frequently Asked Questions:

FAQs

Q1. What factors increase the risk of anastomotic leak after colorectal surgery? Multiple factors contribute to anastomotic leak risk, including patient characteristics such as age, comorbidities (as measured by the Charlson Comorbidity Index), and low albumin levels. Treatment-related factors such as preoperative radiation and chemotherapy, use of immunomodulator medications, and emergency surgery settings also elevate risk. Surgical technique matters significantly—the choice between laparoscopic versus open approaches, stapled versus handsewn anastomosis methods, and the number of major arteries ligated during the procedure all influence outcomes. Additionally, surgeon experience and operative time exceeding three hours are important considerations.

Q2. When do anastomotic leaks typically occur after surgery? Anastomotic leaks most commonly present between postoperative days 5-7, coinciding with the resumption of bowel function. However, the timing can vary considerably, with median diagnosis occurring around days 5-6 but ranging anywhere from 1 to 85 days after surgery. Early leaks (within 5 days) tend to manifest as severe peritonitis requiring emergency intervention, while late leaks often present as persistent pelvic abscesses. This delayed presentation creates the “5-7 day problem” that makes early prediction so valuable for improving patient outcomes.

Q3. How can doctors detect an anastomotic leak? Detection methods include both imaging and clinical assessment. CT scans showing perianastomotic free air or fluid collections raise concern for leakage. Water-soluble contrast enemas performed under fluoroscopy or CT can confirm the presence of a leak. Clinically, doctors monitor for symptoms like abdominal pain, fever, tachycardia, prolonged ileus, and peritonitis. Laboratory biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) measured on postoperative days 3-5 provide objective early warning signs. Newer approaches include AI analysis of surgical images and intraoperative techniques such as air-leak testing.

Q4. What is the accuracy of biomarkers in predicting anastomotic leaks? Biomarkers demonstrate strong predictive performance, particularly for ruling out leaks. CRP measurements on postoperative days 3-4 achieve sensitivities of 72-95% and specificities of 86-90%, with negative predictive values exceeding 95% (up to 99%). Procalcitonin shows even higher sensitivity (100%) at optimal cutoffs when measured on day 3, with specificity of 85-91%. The high negative predictive value means that normal biomarker levels reliably indicate low leak risk, supporting safe early discharge decisions. However, the positive predictive value remains lower at 20-24%, indicating that elevated levels warrant further investigation rather than confirming the diagnosis.

Q5. Can AI systems predict anastomotic leaks better than surgeons? AI systems demonstrate superior accuracy metrics compared to traditional surgeon judgment. Convolutional neural networks trained on laparoscopic images achieve 99.6% accuracy, 99.2% sensitivity, and 100% specificity, significantly outperforming subjective visual assessment. These systems provide real-time intraoperative feedback at 19.2 frames per second, enabling immediate surgical decision-making. However, AI implementation faces practical barriers, including computational requirements, limited availability in resource-constrained settings, and the need for extensive training datasets. While AI shows the greatest potential, biomarker-based approaches currently offer greater practical utility for most institutions.

References:

[1] – https://pmc.ncbi.nlm.nih.gov/articles/PMC10277951/

[2] – https://jamanetwork.com/journals/jamasurgery/fullarticle/400775

[Internal Medicine -Home]

Video Section

Check out our extensive video library (see channel for our latest videos)